Janusz M J, Durham S L
Hoechst Marion Roussel Pharmaceuticals, OH 45215, USA.
Inflamm Res. 1997 Dec;46(12):503-8. doi: 10.1007/s000110050233.
The neutrophil elastase inhibitor MDL 101,146 was examined for its anti arthritic effect and to determine the role of neutrophil elastase in collagen-induced arthritis and adjuvant arthritis.
The collagen-induced arthritis model was performed in female DA rats immunized on day 0 an 1.7 with chick type II collagen in Freund's incomplete adjuvant. Adjuvant arthritis was induced in female Lewis rats by an intradermal injection of heat-killed Mycobacterium tuberculosis H37RA.
The clinical signs of arthritis were assessed, joint swelling was measured using calipers and bone degradation, new bone proliferation, pannus formation and cartilage degradation were evaluated histologically.
MDL 101,146 administered orally inhibited the severity of collagen-induced arthritis as measured by a reduction in clinical score and joint swelling. Histological evaluation demonstrated a bone and cartilage sparing effect of MDL 101,146 in the tibio-tarsal joint of animals with collagen-induced arthritis.
These results suggest that destruction of the joint in collagen-induced arthritis is at least partially due to neutrophil elastase.
研究中性粒细胞弹性蛋白酶抑制剂MDL 101,146的抗关节炎作用,并确定中性粒细胞弹性蛋白酶在胶原诱导性关节炎和佐剂性关节炎中的作用。
在雌性DA大鼠中建立胶原诱导性关节炎模型,于第0天和第1.7天用弗氏不完全佐剂中的鸡II型胶原进行免疫。通过皮内注射热灭活的结核分枝杆菌H37RA诱导雌性Lewis大鼠发生佐剂性关节炎。
评估关节炎的临床症状,用卡尺测量关节肿胀,并通过组织学评估骨降解、新骨增殖、血管翳形成和软骨降解。
口服MDL 101,146可减轻胶原诱导性关节炎的严重程度,表现为临床评分降低和关节肿胀减轻。组织学评估显示,MDL 101,146对胶原诱导性关节炎动物的胫跗关节具有保护骨和软骨的作用。
这些结果表明,胶原诱导性关节炎中关节的破坏至少部分归因于中性粒细胞弹性蛋白酶。